DLA Piper advises Haemonetics Corporation on the sale of its subsidiary, Inlog Holdings France, to Abénex capital

DLA Piper advised Haemonetics Corporation, a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, in connection with the sale of its wholly-owned subsidiary, Inlog Holdings France SAS, to Abénex Capital, a fully independent private equity firm based in France.

Inlog Holdings France SAS, through its subsidiary In Log SAS, develops and sells blood bank and hospital software solutions used predominantly in France and in several other countries outside of the U.S.

Intervenants:

The DLA Piper corporate team was led by partner and Location Head Jeremy Scemama, senior associate Aymeric Robine, senior associate Anthony Guillaume, and associate Mélanie Walusiak.